1. The independent prognostic impact of the GATA2 pioneering factor is restricted to ERG-negative prostate cancer. Issue 7 (July 2019) Authors: Büscheck, Franziska; Zub, Maciej; Heumann, Asmus; Hube-Magg, Claudia; Simon, Ronald; Lang, Dagmar S; Höflmayer, Doris; Neubauer, Emily; Jacobsen, Frank; Hinsch, Andrea; Luebke, Andreas M; Tsourlakis, Maria Christina; Sauter, Guido; Huland, Hartwig; Graefen, Markus; Haese, Alexander; Heinzer, Hans... Journal: Tumor biology Issue: Volume 41:Issue 7(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗